Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VENUS REMEDIES vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VENUS REMEDIES STRIDES PHARMA SCIENCE VENUS REMEDIES/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 15.0 -1,455.3 - View Chart
P/BV x 0.9 3.3 28.9% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 VENUS REMEDIES   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    VENUS REMEDIES
Mar-23
STRIDES PHARMA SCIENCE
Mar-23
VENUS REMEDIES/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs379392 96.6%   
Low Rs145263 55.0%   
Sales per share (Unadj.) Rs415.5408.5 101.7%  
Earnings per share (Unadj.) Rs19.9-25.6 -77.7%  
Cash flow per share (Unadj.) Rs44.01.4 3,218.4%  
Dividends per share (Unadj.) Rs01.50 0.0%  
Avg Dividend yield %00.5 0.0%  
Book value per share (Unadj.) Rs344.3242.8 141.8%  
Shares outstanding (eoy) m13.3790.30 14.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.60.8 78.5%   
Avg P/E ratio x13.2-12.8 -102.8%  
P/CF ratio (eoy) x5.9239.6 2.5%  
Price / Book Value ratio x0.81.4 56.3%  
Dividend payout %0-5.9 -0.0%   
Avg Mkt Cap Rs m3,50129,603 11.8%   
No. of employees `000NANA-   
Total wages/salary Rs m5707,320 7.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5,55536,884 15.1%  
Other income Rs m1031,352 7.6%   
Total revenues Rs m5,65838,236 14.8%   
Gross profit Rs m602830 72.6%  
Depreciation Rs m3232,433 13.3%   
Interest Rs m32,611 0.1%   
Profit before tax Rs m379-2,862 -13.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m114-553 -20.6%   
Profit after tax Rs m266-2,309 -11.5%  
Gross profit margin %10.82.2 481.7%  
Effective tax rate %30.019.3 155.1%   
Net profit margin %4.8-6.3 -76.4%  
BALANCE SHEET DATA
Current assets Rs m3,23031,353 10.3%   
Current liabilities Rs m82629,902 2.8%   
Net working cap to sales %43.33.9 1,100.4%  
Current ratio x3.91.0 373.0%  
Inventory Days Days3771 51.9%  
Debtors Days Days504129 391.7%  
Net fixed assets Rs m2,78131,300 8.9%   
Share capital Rs m134903 14.8%   
"Free" reserves Rs m4,47021,025 21.3%   
Net worth Rs m4,60321,928 21.0%   
Long term debt Rs m38711,398 3.4%   
Total assets Rs m6,01163,734 9.4%  
Interest coverage x130.0-0.1 -135,497.3%   
Debt to equity ratio x0.10.5 16.2%  
Sales to assets ratio x0.90.6 159.7%   
Return on assets %4.50.5 941.7%  
Return on equity %5.8-10.5 -54.8%  
Return on capital %7.7-0.8 -1,018.8%  
Exports to sales %046.7 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA17,213 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m018,113 0.0%   
Fx outflow Rs m0672 0.0%   
Net fx Rs m017,442 0.0%   
CASH FLOW
From Operations Rs m366444 82.5%  
From Investments Rs m-5083,025 -16.8%  
From Financial Activity Rs m-6-2,139 0.3%  
Net Cashflow Rs m-2201,328 -16.6%  

Share Holding

Indian Promoters % 41.8 27.4 152.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 38.9 4.1%  
FIIs % 1.6 19.5 8.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 58.2 72.6 80.2%  
Shareholders   19,560 91,182 21.5%  
Pledged promoter(s) holding % 0.0 69.2 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VENUS REMEDIES With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on VENUS REMEDIES vs STRIDES PHARMA SCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

VENUS REMEDIES vs STRIDES PHARMA SCIENCE Share Price Performance

Period VENUS REMEDIES STRIDES PHARMA SCIENCE S&P BSE HEALTHCARE
1-Day 7.05% 1.16% 1.18%
1-Month -4.10% 0.35% -0.75%
1-Year 103.11% 176.88% 61.82%
3-Year CAGR 4.62% -3.35% 18.16%
5-Year CAGR 58.05% 10.98% 19.79%

* Compound Annual Growth Rate

Here are more details on the VENUS REMEDIES share price and the STRIDES PHARMA SCIENCE share price.

Moving on to shareholding structures...

The promoters of VENUS REMEDIES hold a 41.8% stake in the company. In case of STRIDES PHARMA SCIENCE the stake stands at 27.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of VENUS REMEDIES and the shareholding pattern of STRIDES PHARMA SCIENCE.

Finally, a word on dividends...

In the most recent financial year, VENUS REMEDIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

STRIDES PHARMA SCIENCE paid Rs 1.5, and its dividend payout ratio stood at -5.9%.

You may visit here to review the dividend history of VENUS REMEDIES, and the dividend history of STRIDES PHARMA SCIENCE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.